Format

Send to

Choose Destination
See comment in PubMed Commons below
Acta Med Port. 2008 Sep-Oct;21(5):412-26. Epub 2009 Jan 16.

[Use of granulocyte growth factors: recommendations of the Portuguese Society of Hematology].

[Article in Portuguese]

Author information

1
Serviço de Hematologia e Transplantação de Medula, Hospital de Santa Maria, Lisbon.

Abstract

The administration of cytotoxic chemotherapy may be complicated by the emergence of neutropenia and febrile neutropenia, frequently determining hospital admission and intravenous treatment with broad spectrum antibiotics. Frequently, it is necessary to reduce the dose or to delay the administration of the cytotoxic drugs reducing the relative dose intensity of the chemotherapy regimen. Granulocyte growth factors stimulate the proliferation and differentiation of neutrophils and reduce the number of days of severe neutropenia and febrile neutropenia associated with cytotoxic chemotherapy. They are also indicated for the collection of hematopoietic progenitors for autologous and allogeneic transplantation, as well as in non malignant diseases associated with chronic neutropenia. This article reviews the evidence supporting the use of granulocyte growth factors in Hematology.

PMID:
19187683
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Ordem dos Medicos / Portuguese Medical Association
    Loading ...
    Support Center